- Home
- MTC vs CRIS Comparison
MTC vs CRIS Comparison
Compare MTC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- CRIS
- Stock Information
- Founded
- MTC 2015
- CRIS 2000
- Country
- MTC Hong Kong
- CRIS United States
- Employees
- MTC N/A
- CRIS N/A
- Industry
- MTC Computer Software: Prepackaged Software
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTC Technology
- CRIS Health Care
- Exchange
- MTC Nasdaq
- CRIS Nasdaq
- Market Cap
- MTC 26.4M
- CRIS 21.3M
- IPO Year
- MTC 2019
- CRIS 2000
- Fundamental
- Price
- MTC $0.87
- CRIS $1.71
- Analyst Decision
- MTC
- CRIS Strong Buy
- Analyst Count
- MTC 0
- CRIS 2
- Target Price
- MTC N/A
- CRIS $16.50
- AVG Volume (30 Days)
- MTC 40.9K
- CRIS 72.3K
- Earning Date
- MTC 08-19-2025
- CRIS 08-05-2025
- Dividend Yield
- MTC N/A
- CRIS N/A
- EPS Growth
- MTC N/A
- CRIS N/A
- EPS
- MTC N/A
- CRIS N/A
- Revenue
- MTC $1,868,333.00
- CRIS $11,405,000.00
- Revenue This Year
- MTC N/A
- CRIS N/A
- Revenue Next Year
- MTC N/A
- CRIS $9.52
- P/E Ratio
- MTC N/A
- CRIS N/A
- Revenue Growth
- MTC N/A
- CRIS 12.24
- 52 Week Low
- MTC $0.76
- CRIS $1.02
- 52 Week High
- MTC $6.42
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- MTC 40.31
- CRIS 42.22
- Support Level
- MTC $0.90
- CRIS $1.55
- Resistance Level
- MTC $0.90
- CRIS $1.82
- Average True Range (ATR)
- MTC 0.04
- CRIS 0.12
- MACD
- MTC -0.00
- CRIS 0.01
- Stochastic Oscillator
- MTC 9.54
- CRIS 48.48
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.